SynAct Pharma partners with Hipolabor on dengue drug in Brazil
SynAct Pharma has partnered with Hipolabor to develop and commercialize resomelagon for dengue in Brazil.
SynAct Pharma has partnered with Hipolabor to develop and commercialize resomelagon for dengue in Brazil.